DFE Pharma is jointly owned by Royal FrieslandCampina, one of the world’s top multi-national dairy companies, and CVC Capital Partners, a leading global investor that recently acquired 50% share. DFE Pharma has production locations in the Netherlands, Germany, New Zealand and India.Global Sales offices in Germany, the United States, Singapore, Japan, India, Brazil and China are responsible for the sales in more than 100 countries worldwide. The company currently employs 360 people based in 9 countries.
Our company is in pursuit of excipient excellence, and we aim to become acknowledged global leaders in our field. Our goal is leadership in all forms of expertise related to excipients, from original research to hands-on client support. We work every day to offer new options to the market, to improve supply and minimize time to market. Our excipient portfolio today is perhaps the most comprehensive in the market, ranging from starch, lactose and MCC to inhalants and superdisintegrants.